Cite
APA Citation
Mujtaba, M. A., Komocsar, W. J., Nantz, E., Samaniego, M. D., Henson, S. L., Hague, J. A., Lobashevsky, A. L., Higgins, N. G., Czader, M., Book, B. K., Anderson, M. D., Pescovitz, M. D., & Taber, T. E. (n.d.). effect of Treatment With Tabalumab, a B Cell–Activating Factor Inhibitor, on Highly Sensitized Patients With End‐Stage Renal Disease Awaiting Transplantation. American journal of transplantation, 16(4), 1266–1275. http://access.bl.uk/ark:/81055/vdc_100031259407.0x00000c